Pancreatic stone protein is a promising biomarker for early sepsis detection. With rapid point-of-care testing & strong diagnostic performance, PSP can help identify high-risk ICU patients earlier. Read more: https://t.co/tpn7QvA1dl
The 2026 Surviving Sepsis Campaign guidelines mark a shift toward personalised, physiology-driven sepsis care with earlier vasopressor use, dynamic fluid assessment, and more precise haemodynamic management. Read more: https://t.co/VqUsIau5aJ #AOPHealth
Latest Insights on #Sepsis: Updated Surviving Sepsis Campaign Guidelines for Management of Sepsis & Septic Shock; Definition of Refractory Septic Shock: Consensus from SCCM & ESICM; Transformative Potential of Pancreatic Stone Protein. Read more: https://t.co/fCeMZ66nGc
Prof Michel Slama, Chairman of Critical Care Medicine at Amiens University Hospital, France, discusses when and why beta-blockade should be considered in critically ill patients #AOPHealth. Watch here: https://t.co/ajfl5ftJkk
Achieving effective rate control in critically ill patients remains challenging. Current evidence supports landiolol’s rapid onset, short half-life, and favourable haemodynamic profile in critical care settings. Read more: https://t.co/TLwd5y4ozd #AOPHealth
Tele-critical care functions as core critical care infrastructure, achieving reliable outcomes through intentional leadership, standardised processes, and strong collaboration between virtual and onsite teams. Read more here: https://t.co/ofMyZw8qGg
Tele-ICUs were built to extend scarce expertise, but they’ve mostly moved data, not true clinical understanding. The problem isn’t data scarcity; it’s context loss. The future: autonomous, self-supervised models. Read more here: https://t.co/JjI5yY6Rl1
ECMO is no longer confined to the ICU. This article explores how mobile ECMO systems are enabling safe transport across hospitals, and even in the air.
Read more: https://t.co/GqcJ7C4cgO #ECMO#CriticalCare#ICU#ISICEM Lifemotion® ECMO system
Effective rate control in critically ill patients is challenging. Evidence continues to support landiolol’s rapid onset, short half-life and favourable haemodynamic profile in critical care. Read more: https://t.co/Fg5TeMWlkx #ICU#ISICEM#AOPHealth
Can biomarkers help detect #sepsis earlier? This question will be at the centre of Sepsis Session @ISICEM. Prof Andrew Shorr will discuss “Old and New Biomarkers”, sharing insights from data on Pancreatic Stone Protein. Mar 17 | 2:15 PM | Salle M https://t.co/NZK2EPmTxv
What are the challenges of integrating circadian medicine into critical care, what steps can address these challenges and which recommendations can guide clinical implementation? Learn more here: https://t.co/TLCW1QgCFN
A precision strategy approach combining early recognition of interleukin (IL)-1 activation with anakinra treatment to improve pneumonia outcome. Here's a quick summary of the INSPIRE trial: https://t.co/I8qk7AKzS9